UroGen Pharma Ltd. (LON:0XOD)

UroGen Pharma Revenue

UroGen Pharma had revenue of $20.25M USD in the quarter ending March 31, 2025, with 7.84% growth. This brings the company's revenue in the last twelve months to $91.87M, up 8.98% year-over-year. In the year 2024, UroGen Pharma had annual revenue of $90.40M with 9.29% growth.

• Revenue (ttm): $91.87M
• Revenue Growth: +8.98%
• P/S Ratio: 6.84
• Revenue / Employee: $390.94K
• Employees: 235
• Market Cap: 486.40M GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	90.40M	7.69M	9.29%
Dec 31, 2023	82.71M	18.36M	28.52%
Dec 31, 2022	64.36M	16.32M	33.96%
Dec 31, 2021	48.04M	36.24M	307.17%
Dec 31, 2020	11.80M	11.78M	65,450.00%